Literature DB >> 15606654

Contact urticaria from Emla cream.

J Waton1, A Boulanger, P H Trechot, J L Schmutz, A Barbaud.   

Abstract

We report the first case of immediate-type hypersensitivity caused by Emla cream. A 55-year-old woman, after using Emla cream, went on to develop urticaria. An open test was positive to Emla cream. Patch tests and prick tests were performed with Emla cream, the components of Emla cream (lidocaine, prilocaine and castor oil) and other local anaesthetics. The patch test with lidocaine and the prick test with Emla cream were both positive. An intradermal test and subcutaneous administration of 3 anaesthetics that had negative patch tests and prick tests were performed and well tolerated, allowing their use. In the literature, anaphylactic reactions to lidocaine injections, delayed-type hypersensitivity after lidocaine subcutaneous injections and contact dermatitis from Emla cream have all been described. This first case of contact urticaria from Emla cream was due to lidocaine and did not show any cross-reaction with other local anaesthetics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15606654     DOI: 10.1111/j.0105-1873.2004.00475.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  5 in total

1.  Anesthesia methods in laser resurfacing.

Authors:  Sergio Gaitan; Ramsey Markus
Journal:  Semin Plast Surg       Date:  2012-08       Impact factor: 2.314

2.  Ulcerative vulvar irritant contact dermatitis from eutectic mixture of local anesthetics cream in 2 patients.

Authors:  Amy Zeglinski-Spinney; Carly Kirshen
Journal:  JAAD Case Rep       Date:  2022-06-02

Review 3.  Drug-induced urticarias.

Authors:  Pascale Mathelier-Fusade
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

4.  Percutaneous dermal drug delivery for local pain control.

Authors:  Sujatha Tadicherla; Brian Berman
Journal:  Ther Clin Risk Manag       Date:  2006-03       Impact factor: 2.423

5.  Contact urticaria syndrome caused by haptens.

Authors:  Krzysztof Gomułka; Bernard Panaszek
Journal:  Postepy Dermatol Alergol       Date:  2014-04-22       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.